Market: NMS |
Currency: USD
Address: 69 Yonge Street
ZenaTech, Inc., an enterprise software technology company, develops cloud-based software applications in Canada. It provides cloud-based enterprise software solutions for the medical records industry; software solutions for the automated facility management and center industry; safety and compliance management software and mobile solutions; field management software and mobile solutions; and browser-based enterprise software applications for public safety. The is also engages in the manufacturing, sale, and distribution of drones. ZenaTech, Inc. was formerly known as ZenaDrone, Inc. and changed its name to ZenaTech, Inc. on October 5, 2020. The company was incorporated in 2017 and is based in Toronto, Canada.
📈 N/A Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$7.14
-
Upside/Downside from Analyst Target:
57.01%
-
Broker Call:
2
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
<0%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
200-500%
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for N/A
| Date | Reported EPS |
|---|
| 2025-08-11 | -0.19 |
📰 Related News & Research
-
Haymaker Acquisition Corp. 4 Non-Redemption Agreement: Terms, Shareholder Obligations, and Payment Details for Business Combination 1
April 7, 2026
Haymaker Acquisition Corp. 4: Non-Redemption Agreement Detai...
-
SolarMax Technology Reports 296% Revenue Growth and Major EPC Contract Wins in Fiscal Year 2025 Financial Results
April 7, 2026
SolarMax Technology, Inc. Reports Explosive Revenue Growth a...
-
Chemung Financial Corporation Files Form 8-K with NASDAQ Listing and Company Details (April 3, 2026) 22
April 7, 2026
NIL Disclaimer: This article is for informational purposes o...
-
ZEO ScientifiX Advances to XPRIZE Healthspan Semi-Finals with Regenerative Biologics Platform 1
April 7, 2026
ZEO ScientifiX Advances in \$101 Million XPRIZE Healthspan C...
-
Cue Biopharma, Inc. Files Form 8-K SEC Report for April 2026 – Company Details, Stock Information, and Executive Signature
April 7, 2026
Cue Biopharma, Inc. 8-K Filing - Investor Report Cue B...
-
Artelo Biosciences Regains Nasdaq Compliance and Advances Clinical Pipeline for Cancer and Pain Treatments
April 7, 2026
Artelo Biosciences Regains Nasdaq Compliance and Advances Pi...
-
SuRo Capital to Transition to External Management with Magnetar Joint Venture; Reports Higher Q1 2026 NAV
April 7, 2026
SuRo Capital Corp. Announces Major Strategic Shift: Transiti...
-
Inhibikase Therapeutics Enrolls First Patient in Global Phase 3 IMPROVE-PAH Study for Pulmonary Arterial Hypertension Treatment 1
April 7, 2026
Inhibikase Therapeutics Reports Key Milestone in PAH Program...
-
Runway Growth Finance Corp. Closes $249 Million Acquisition of SWK Holdings, Expanding Healthcare and Life Sciences Portfolio
April 7, 2026
Runway Growth Finance Corp. Closes Acquisition of SWK Holdin...
-
Prairie Operating Co. 8-K Filing Details: Common Stock, NASDAQ Listing, Company Information (April 2026)
April 7, 2026
Prairie Operating Co. Announces Amendment to Securities Purc...
🔍 View more Reports
